Articles tagged with Side Effects
A new study by Ohio State University researchers has made significant strides in ensuring the safe and effective transfusion of artificial blood substitutes. The key to improved safety lies in the size of the artificial blood molecule, with larger sizes reducing cardiovascular side effects.
Researchers developed a simple sensor to monitor paracetamol levels in saliva in real-time, enabling personalized treatment and reducing toxic side effects. The device is low-cost, portable, and uses non-invasive collection methods, making it an attractive alternative for therapeutic drug monitoring.
A nurse has shared her experience of developing sudden sensorineural hearing loss (SSNHL) after a mild COVID-19 infection. She highlights the importance of clinicians including SSNHL as a potential side effect of COVID-19 and recommends high-dose corticosteroids as treatment.
Researchers developed a complex that accumulates in tumour tissue and is activated by ultrasound waves, triggering the release of a toxic compound and eradicating tumours. This method could make cancer treatment less invasive and more effective for large and deep-seated tumours.
Researchers propose conjugating a cell-penetrating peptide to oxaliplatin to overcome chemotherapy resistance in colorectal cancer. The new approach reduces platinum accumulation in tumour microenvironment and healthy tissues.
A new class of compounds reduces weight dramatically and lowers blood glucose in lab animals, boosting calorie burn and avoiding nausea. The injectable treatments activate multiple gut hormone receptors, including GLP-1 and PYY, to signal fullness and curb appetite.
Researchers debunk rock'n'roll myth, finding narcotics have no effect on inspiration. Instead, complex training programs, meditation, and cultural exposure boost creativity. Training that highlights mental techniques has long-term impacts, while mindfulness activities like meditation also improve imagination in the short term.
Researchers found that senescence-associated exosomes (SA-EXOs) from MSCs induce fibrosis and activate invasive characteristics in neighboring cells via the TGF-β pathway. SA-EXOs play a large role in cancer-related fibrosis, and their unique miRNA content influences myofibroblast phenotypes.
A recent study found that the side effects of treating brain diseases with antisense oligonucleotides are related to altered calcium balance. By modulating calcium levels, researchers hope to reduce neurotoxicity and improve treatment outcomes for various neurological diseases.
A new review paper suggests that selective protection of normal cells from chemotherapy could increase the therapeutic window and improve outcomes for cancer patients. The authors propose using antagonistic drug combinations to kill drug-resistant cancer cells, reducing side effects and improving quality of life.
Researchers identified microglia as key players in chemo brain inflammation, suggesting a potential target for treatment. In a mouse study, deleting microglia restored memory and lowered brain inflammation after paclitaxel treatment.
A recent study found that 27% of twelfth graders in medical marijuana states reported vaping cannabis, compared to 19% in states where all adult use is prohibited. The researchers suspect that the context of medical cannabis and availability may contribute to the higher rates of teen vaping.
Researchers investigated a remote dietary intervention to reduce chronic cancer-related fatigue in lymphoma survivors, with encouraging preliminary data suggesting effectiveness. Participants showed significant improvement in self-reported fatigue and overall healthful eating patterns.
A new study by the University of Bristol has found that spironolactone can help preserve the glycocalyx layer on blood vessels in the kidneys, reducing damage from diabetes. This discovery could lead to more effective treatments for diabetic kidney disease without adverse side effects.
A new study found that tailoring medication doses to a patient's DNA leads to a 30% reduction in serious side effects. The 'DNA medication pass' allows doctors and pharmacists to adjust prescriptions based on a patient's genetic profile, resulting in improved effectiveness and safety.
A study found that immune checkpoint inhibitors enhance chemotherapy-induced neuropathic pain by blocking interaction between macrophages and neurons via PD1-PDL1 synergy. This discovery could lead to the development of therapeutic alternatives to prevent pain while maintaining anti-neoplastic effects.
Researchers successfully treated a young man with recurrent non-gonococcal urethritis caused by Mycoplasma genitalium using chloramphenicol. The patient showed improvement after 14 days of treatment, despite initial failure with first and second-line antibiotics.
Researchers found that female patients with diffuse large B-cell lymphoma treated in the afternoon had reduced mortality rates and cancer recurrence compared to those treated in the morning. The study suggests that timing chemotherapy delivery according to an individual's circadian clock may improve treatment outcomes.
A study published in the Journal of the American Geriatrics Society found a sharp increase in cannabis-related emergency department visits among California adults ages 65 and older from 2005 to 2019. The rate increased by 1,808%, with more than 12,000 visits reported in 2019.
Researchers have made a breakthrough in precision oncology for patients with metastatic urothelial carcinoma, identifying that certain cell surface molecules decrease or are absent in these patients, making them resistant to the new drug enfortumab vedotin.
The article discusses the use of Rapamycin in the context of Pascal's Wager, a philosophical framework used to justify beliefs. ChatGPT's generative pre-trained transformer model provides an exhaustive research perspective on the pros and cons of taking Rapamycin for anti-aging purposes.
A cost-effectiveness analysis of direct oral anticoagulants (DOACs) versus low-molecular-weight heparin (LMWH) for cancer-associated thrombosis found that DOACs are more medically effective and cost-effective. The most cost-effective DOAC, apixaban, was also shown to be the least costly anticoagulant.
Researchers at IU School of Medicine discovered a genetic variant that may increase the risk of heart damage from anthracycline-based chemotherapy. The study found that this variant can be predicted using human iPSC-derived cardiomyocytes, and potential strategies to prevent cardiotoxicity are being explored.
A team at Massachusetts General Hospital found that skin produces β-endorphin in response to radiation therapy, contributing to fatigue. Blocking this hormone with opiate antagonist drugs might benefit patients.
A recent study led by Stefan Seidel found that light therapy significantly improves fatigue symptoms in Multiple Sclerosis patients, with measurable improvements observed after just 14 days of use. The study used objective measurements to rule out sleep disorders, which are common comorbidities with fatigue in MS patients.
A recent study published in Nature Cardiovascular Research found a link between COVID-19 and postural orthostatic tachycardia syndrome (POTS), with patients infected five times more likely to develop the condition. Vaccination was also linked, but at a lower risk, emphasizing the importance of vaccination in reducing POTS.
The Cochrane review analyzed data from 41 randomized controlled trials of 12 different COVID-19 vaccines, involving 433,838 people worldwide. The review found that most vaccines reduced the risk of COVID-19 infection and severe disease, with few reported side effects.
A new study found that earlier vaccine hesitancy predicts subsequent nocebo side-effects following the booster vaccination. Only 16% of one’s vaccine side effects were explained by earlier vaccine hesitancy, highlighting the importance of tailored public health messaging.
Researchers found that dimethyl fumarate treatment increased the proportion of beneficial gut bacteria and reduced pro-inflammatory types, which are associated with MS. The study suggests a potential connection between gut flora and clinical side effects, paving the way for personalized treatment approaches.
Researchers link fentanyl to sodium pockets in nerve cell receptors, blocking harmful side effects while reducing pain. The study offers promise for safer painkillers and potential improvements for addressing the nation's crisis of addiction and overdose.
Researchers are developing new male birth control options that could provide a safer and more effective alternative to hormonal methods. Non-hormonal approaches targeting proteins essential for sperm production are showing promise in clinical trials with minimal side effects.
A new non-hormonal gel blocks sperm by reinforcing cervical mucus barrier, demonstrating high effectiveness in reducing uterine sperm numbers. The gel has shown a 98% average decrease in sperm numbers compared to untreated control animals, making it a promising alternative to existing contraceptives.
Patients with high-risk stage III-IV melanoma who received pembrolizumab after surgery reported better quality of life than those on ipilimumab or high-dose interferon. The treatment also reduced disease recurrence and improved overall survival.
A study published in Oncotarget found that APOE genotype is associated with the presence and severity of cancer treatment-related side effects and symptoms, as well as the response to exercise-based interventions in cancer survivors. ApoE4 carriers showed a lower fall rate after exercise intervention compared to non-carriers.
A large-scale study found anabolic-androgenic steroid use is relatively common among Canadian adolescents and young adults, associated with dependence and serious side effects. Nearly 1 in 4 steroid users experienced moderate or severe dependence and adverse health issues.
A pooled data analysis of 10 randomized controlled trials involving 1040 women found that acupuncture significantly relieved pain during pregnancy, improved physical function, and quality of life. The therapy was also found to be safe, with no observable major side effects for newborns.
A study by Edith Cowan University found that home-based exercise programs can accelerate recovery from cancer-related fatigue and improve health-related quality of life during radiotherapy. The research included 89 women who completed a 12-week program, with no adverse effects reported.
A new calculator will assess an individual's risk and benefit of taking bisphosphonates for osteoporosis, considering factors such as fracture history and comorbid conditions. The calculator aims to provide personalized guidance on whether a drug holiday is beneficial or not.
Scientists have identified a potential therapy to reduce the side effects of cisplatin chemotherapy, which can cause kidney toxicity and neuropathic pain. Istradefylline, an approved Parkinson's disease drug, has been found to mitigate these harmful effects while preserving cisplatin's anti-tumor properties.
A recent study by the Universities of Bonn and Shanxi found that Covid-19 vaccination stimulates immune response, enabling anti-PD-1 therapy to work better against nasopharyngeal cancer. Vaccinated patients responded significantly better to cancer therapy than unvaccinated counterparts.
A study found that males younger than 40 years old who received the Moderna COVID-19 vaccine had the highest rates of myocarditis, but overall cases are rare. The study suggests that choosing specific vaccines for certain populations may maximize benefits and minimize adverse events.
A new preclinical study discovered the underlying cause of gender differences in immunotherapy-associated myocarditis and identified potential treatment strategies. Hormone therapies targeting the endocrine-cardiac-immune pathway may reduce this risk without affecting treatment efficacy.
In the ARROS-1 trial, 48% of patients achieved partial responses to NVL-520, with responses seen across all dose levels and in heavily pre-treated patients. The treatment also showed promise for brain metastases, with three out of three patients experiencing measurable response or no emergence of new metastases.
A Phase Ib clinical trial found that sequential administration of PARP inhibitor olaparib and WEE1 inhibitor adavosertib is safe and well-tolerated, with promising signs of anti-tumor activity in patients with advanced cancers driven by DNA damage response mutations. The combination showed durable responses in patients with resistant c...
A new experimental drug has shown promising results in treating liver cancer, with two patients experiencing a partial response to the treatment. The drug, NMS-01940153E, targets an enzyme that plays a critical role in cell division and growth, and its side effects are manageable.
The THERACAT project aims to deliver drugs only to tumor sites using bio-orthogonal catalysis, a promising approach for targeted cancer treatment. Researchers developed nanoparticles bearing metal catalysts to efficiently convert inactive pro-drugs into active drugs at the tumor site.
Researchers have found a drug that targets the key, cancer-causing gene MYC has been able to inhibit its function safely and effectively. Eight out of 12 patients showed stabilisation of disease after treatment with OMO-103, with one patient experiencing a reduction in tumour-derived DNA circulating in the blood stream.
Researchers have developed a drug compound that stops cancer cell growth in mice with little effect on normal healthy cells, making it potentially nontoxic for patients. The therapy targets the epidermal growth factor receptor gene, which is overexpressed in about half of all triple-negative breast cancer cases.
Researchers analyzed three intervention strategies to mitigate mercury use and emissions in artisanal gold mining, finding that while some methods reduce emissions, others create new environmental problems. The study suggests a need for more comprehensive approaches to address the complex issues surrounding mercury use.
In a first-in-human trial, FLASH radiation treatment was found safe and effective for pain relief in patients with bone metastases. The study showed significant pain relief in 7 out of 10 patients, with minimal side effects.
A new study found that sexual side effects of cancer treatment are discussed less frequently with female patients, who are asked about their sexual health 1 in 10 times, compared to 9 in 10 men. The disparity is also observed in clinical trials nationwide.
A meta-analysis of six studies concludes that electroconvulsive therapy (ECT) is more effective than ketamine in quickly relieving major depression symptoms. The analysis, published in JAMA Psychiatry, found no significant differences in ECT's success rate across various age groups and geographic locations.
A study found that patients receiving CAR T-cell therapy were more likely to develop neurological side effects, including ICANS, when they had hypophosphatemia. The researchers suggest that serum phosphate measurements could be used to predict the onset of ICANS in these patients.
A new study found that hormone therapy experiences differ significantly by race among women experiencing menopause symptoms. White women reported higher rates of hormone therapy use and better quality of life compared to women of other ethnicities.
Researchers analyzed 408 patients receiving immune checkpoint inhibitor therapy and found no increased risk of side effects from receiving both immunotherapy and the vaccine. The study supports NCCN's recommendations for COVID-19 vaccination in people with cancer, citing strong protection against severe COVID-19 for all variants.
A Swedish cohort study found that direct oral anticoagulants (DOACs) were associated with a lower risk of kidney function decline or kidney failure compared to vitamin K antagonists (VKA). DOACs also showed a lower risk of acute kidney injury.
Researchers found that inhibiting GABA A receptors protects intestinal stem cells from chemotherapy and radiotherapy-induced damage, reducing DNA damage and increasing survival. Flumazenil, an FDA-approved anti-sedative, shows promise in protecting the intestine from these toxic effects.
The study found a significant decline in peritoneal dialysis-associated peritonitis rates over time, with consistent differences in risk by race and age. The decline suggests improvements in clinical practice and highlights the importance of uniform coding standards to identify additional risk factors.
A study from the University of Gothenburg found that the number of surgeries performed by a urology surgeon has no effect on men's risk of developing postoperative urinary incontinence after prostate cancer surgery. The researchers analyzed data from over 4,600 men who underwent robot-assisted radical prostatectomy between 2017 and 2019.
Scientists at Aston University developed a new treatment combining manuka honey with the widely used antibiotic amikacin to treat drug-resistant lung infections. The study found that this combination improved bacterial clearance and reduced side effects, benefiting patients with cystic fibrosis.